Detail akcie LeMaitre online

Business Summary: LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, LeMaitre Vascular Inc revenues increased 13% to $185.1M. Net income increased 28% to $42.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Dividend per share increased from $0.48 to $0.60. Basic Earnings per Share excluding Extraordinary Items increased from $1.46 to $1.86.